menu
    • menu

    Company profile for Cellectis

    NEW Drugs in Dev: 11
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. Cellectis is focused on addressing the medical and food needs of an ever-growing global population through the use of proprietary gene-editing technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellectisFrance Flag
    Country
    Country
    France
    Address
    Address
    8 rue de la Croix Jarry 75013 Paris
    Telephone
    Telephone
    +33 (0)1 81 69 16 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellectis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cellectis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cellectis?lang=fr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellectis' Cema-Cel Shows Strength In Pivotal Trial Interim Data
    Cellectis' Cema-Cel Shows Strength In Pivotal Trial Interim Data

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272912/0/en/Cema-Cel-Pivotal-Trial-Interim-Data-Highlight-Strength-of-Cellectis-Allogeneic-CAR-T-Platform.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Monthly information on share capital and company voting rights
    Monthly information on share capital and company voting rights

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269651/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Cellectis Reveals 2025 Financials Result And Business Update
    Cellectis Reveals 2025 Financials Result And Business Update

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259513/0/en/Cellectis-Reports-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Cellectis To Release 2025 Financial Results On March 19, 2026
    Cellectis To Release 2025 Financial Results On March 19, 2026

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255153/0/en/Cellectis-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-19-2026.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Monthly information on share capital and company voting rights
    Monthly information on share capital and company voting rights

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249751/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Monthly Share Capital and Voting Rights Update
    Monthly Share Capital and Voting Rights Update

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232531/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search